Differentiated thyroid carcinomas with vascular invasion: A comparative study of follicular, Hürthle cell and papillary thyroid carcinoma

Pathology

Volumn 34, Issue 3, 2002, Pages 239-244

  Mai, K T ^a   Khanna, P ^b   Yazdi, H M ^a   Perkins, D G ^a   Veinot, J P ^a   Thomas, J ^a   Lamba, M ^a   Nair, B D ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Follicular carcinoma; H rthle cell; Papillary carcinoma metastasis; Thyroid; Vascular invasion

Indexed keywords

ADULT; AGE; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; FOLLICULAR CARCINOMA; FOLLOW UP; HUMAN; HUMAN TISSUE; METASTASIS POTENTIAL; THYROID CARCINOMA; THYROID FOLLICLE; THYROID PARAFOLLICULAR CELL; TUMOR DIFFERENTIATION; TUMOR VOLUME; ADENOCARCINOMA; METASTASIS; MIDDLE AGED; ONCOCYTOMA; PAPILLARY CARCINOMA; PATHOLOGY; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ADENOMA, OXYPHILIC; ADULT; CARCINOMA, PAPILLARY; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; THYROID NEOPLASMS;

EID: 0035985924     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313020220131291     Document Type: Article

References (46)

1. Follicular carcinoma
2. Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment
3. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma
4. Prognostic indices for tumor relapse and tumor mortality in follicular thyroid carcinoma
5. Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings
6. Papillary carcinoma
7. Prognostic importance of vascular invasion in papillary thyroid carcinoma
8. Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases
9. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy
10. Follicular neoplasms of the thyroid. A study of 44 cases followed for a minimum of 10 years, with emphasis on differential diagnosis
11. Tumors with oncocytic features
12. Pulmonary metastasis of differentiated thyroid carcinoma: Treatment results in 101 patients
13. Invasive Hurthle cell carcinoma of the thyroid: Natural history and management
14. Molecular basis of hurthle cell papillary thyroid carcinoma
15. Hurthle cell carcinoma of the thyroid gland. A tumor of moderate malignancy
16. The oncocytic variant of papillary carcinoma of the thyroid: A clinicopathologic study of 15 cases
17. Metastatic minimally invasive (encapsulated) follicular and Hurthle cell thyroid carcinoma: A study of 34 patients
18. Follicular and Hurthle cell carcinomas of the thyroid: A comparative study
19. Follicular and Hurthle cell carcinoma: Predicting outcome and directing therapy
20. Immunohistochemical study of papillary thyroid carcinoma and possible papillary thyroid carcinoma-related benign thyroid nodules
21. Papillary thyroid carcinoma and related thyroid neoplastic lesions: A light microscopic study with emphasis on nuclear changes
22. Neoplastic non-papillary thyroid carcinoma lesions with a fine chromatin pattern
23. Infiltrating papillary thyroid carcinoma: Review of 134 cases of papillary carcinoma
24. Follicular adenoma with papillary architecture: A lesion mimicking papillary thyroid carcinoma
25. Prognostic factors in differentiated carcinoma of the thyroid gland
26. Thyroid cancer. Survival in 148 cases followed for 10 years or more
27. Prognostic importance of various clinicopathological features in papillary thyroid carcinoma
28. Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: Initial manifestations, pathologic findings, therapy, and outcome
29. Prognostic factors in follicular carcinoma of the thyroid
30. Bone metastases from thyroid carcinoma
31. The encapsulated follicular carcinoma of the thyroid. A clinicopathologic study of 35 cases
32. Molecular analysis of new subtypes of ELE/RET rearrangements, their reciprocal transcripts and breakpoints in papillary thyroid carcinomas of children after Chernobyl
33. Chromosomal breakpoint positions suggest a direct role for radiation in inducing illegitimate recombination between the ELE1 and RET genes in radiation-induced thyroid carcinomas
34. Thyroid carcinomas in RET/PTC transgenic mice
35. Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure
36. Gene rearrangement and Chernobyl related thyroid cancers
37. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: A strong correlation between RET/PTC3 and the solid-follicular variant
38. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation
39. Expression of wild-type ret, ret/PTC and ret/PTC variants in papillary thyroid carcinoma in Germany
40. Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia
41. RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas
42. High frequency of rearrangement of the RET protooncogene (RET/PTC) in Chinese papillary thyroid carcinomas
43. Ret oncogene activation in papillary thyroid carcinoma: Prevalence and implication on the histological parameters
44. Sporadic ret-rearranged papillary carcinoma of the thyroid: A subset of slow growing, less aggressive thyroid neoplasms?
45. Colloid goiter metastasizing into the temporal region
46. Benign metastasizing goiter